Acorda Theraputics
CV 6.0% · CUSIP 00484MAB2
1
institutional holders
+0 vs Q4 2021
$5.0mprincipal reported held*
$3.8mreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2020 | 1 |
| Q2 2020 | 1 |
| Q3 2020 | 1 |
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 1 |
| Q3 2021 | 1 |
| Q4 2021 | 1 |
| Q1 2022 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 1 | 0 |
| Q3 2021 | 1 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 0 |
Holders, Q1 2022
| Manager | Shares | Change |
|---|---|---|
| Bruce & Co., Inc. 0.77% of their portfolio | 5.0m $3.8m | Unchanged |